A Prospective, Phase 4, Open-Label, Twelve-Week Study to Examine the Cognitive Impact and Tolerability of Levetiracetam (Keppra) in Elderly Patients With Seizures of Partial Onset.
Phase of Trial: Phase IV
Latest Information Update: 24 Jun 2015
At a glance
- Drugs Levetiracetam (Primary)
- Indications Dementia; Seizures
- Focus Therapeutic Use
- 22 Jun 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 24 Mar 2011 New trial record